Ranking · Summer 2023 · Healthcare · Drug Discovery and Delivery

Olio Labs

Combination therapeutics for the world's toughest diseases

4.5%

odds of being acquired in the next two years

0.7× the average (6.8%)

#3829 of 4,339 active YC companies · top 89%

Team of 5 · Remote

Raises the odds

↑ based in Fully Remote

↑ team of 3–5

↑ based in Remote

Lowers the odds

↓ industry: Healthcare

↓ “world” in its one-liner

↓ sector: Drug Discovery and Delivery

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Olio Labs's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

oliolabs.co YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub